(MENAFN- GlobeNewsWire - Nasdaq) The European Respiratory Care Devices Market is poised to grow from USD 6.8 billion in 2024 to USD 12.97 billion by 2033, with a CAGR of 7.45%. Key drivers include rising respiratory diseases, an aging population, and advancements in technology. Increased pollution, demand for homecare, and enhanced post-COVID-19 awareness further boost market growth. Notable trends involve AI-powered devices and portable oxygen concentrators, which enhance patient convenience. Supportive healthcare infrastructure and favorable government policies enhance market momentum, despite challenges like high device costs and regulatory hurdles. Key regions include Germany, France, and the UK.Dublin, July 04, 2025 (GLOBE NEWSWIRE) -- The "Europe Respiratory Care Devices Market Size and Share Analysis - Growth Trends and Forecast Report 2025-2033" report has been added to ResearchAndMarkets.com's offering.
The Europe Respiratory Care Devices Market is expected to reach US$ 12.97 billion by 2033 from US$ 6.8 billion in 2024, with a CAGR of 7.45% from 2025 to 2033.
Increased respiratory diseases, a growing population of older people, increased pollution, technological advancements, the demand for homecare, and post-COVID-19 consciousness are the key drivers for the respiratory care devices market in Europe. Supportive healthcare infrastructure and government schemes also promote the use and funding of advanced respiratory therapies.
A medical device that helps patients with respiratory issues or breathing issues is referred to as a respiratory care device. Asthma, chronic obstructive pulmonary disease (COPD), sleep apnea, and acute respiratory infections are some of the conditions that these devices help diagnose, monitor, and treat. New gadgets offer greater patient comfort, automation, and mobility due to technological advances. They are critical for management of respiratory disorders of long-term duration, improving the quality of life, and reducing the rate of hospitalization or admission.
Respiratory care equipment market across Europe is growing because of several interrelated factors. The demand for diagnostic and therapeutic instruments is increasing as a consequence of the significant increase in respiratory illnesses like asthma, COPD, and sleep apnea. The local population's aging increases their vulnerability to respiratory diseases, which propels market growth.
Smart inhalers, AI-powered monitoring devices, and portable oxygen concentrators are some of the technological advancements that enhance patient convenience and efficacy of treatment. Hospital reliance is reduced by a growing need for home healthcare, facilitated by small and easy-to-use technology. Broader use and quicker market growth across Europe are also aided by favorable government policies, expenditure on healthcare, and streamlined regulatory frameworks.
Growth Drivers for the Europe Respiratory Care Devices Market
Rising prevalence of respiratory disease
The European respiratory care equipment market is expanding largely because respiratory diseases have become more widespread in the region. The incidence of conditions such as sleep apnea, asthma, and chronic obstructive pulmonary disease (COPD) are increasing in the region. For instance, in Germany, asthma impacts nearly 10% of children and 4-5% of adults.
The demand for treatment, monitoring, and diagnostic devices like CPAP machines, nebulizers, oxygen concentrators, and inhalers has risen with the growing incidence of respiratory diseases. Some of the causes that contribute to the prevalence of these diseases include environmental pollution, smoking, urbanization, and aging populations. To effectively manage and treat such prevalent diseases, healthcare systems are therefore relying increasingly on advanced respiratory care devices. The increasing market opportunities for European producers of respiratory care devices are underscored by this increasing demand.
Technological Advancements
The European respiratory care equipment market is growing at a fast rate due to technological innovation. Improved treatment outcomes and compliance from patients are being promoted through innovations such as smart inhalers, mobile nebulizers, and ventilators with integrated AI. For instance, MAGNET GROUP and KoKo, LLC, a British spirometer manufacturer, entered into a three-year deal in March 2022.
Under this collaboration, MAGNET GROUP can leverage KoKo's advanced lung function software and diagnostics to improve spirometry and other respiratory testing functionalities. Remote patient management is also becoming more convenient with the use of telemedicine and cloud-based monitoring technologies, especially in homecare environments. Apart from enhancing patient outcomes, these innovations are creating new markets for European device manufacturers.
Ageing Population
One of the prime drivers of Europe's respiratory care equipment market is the aging of the population. As age increases, lung capacity naturally decreases and comorbidities increase, which exposes people to respiratory ailments such as asthma, sleep apnea, and COPD. Based on the European Commission, almost one-fifth (21.6%) of the estimated 449.3 million individuals residing in the EU as of January 1, 2024, were aged 65 years and above.
To effectively treat these diseases, there is an increased demand for respiratory care devices, including CPAP machines, nebulizers, and portable oxygen concentrators. In addition to this, older people's preferences for home services promote the implementation of breathing machines that are not difficult to utilize. This movement highlights the extremely important role that respiratory care machinery plays in the improvement of Europeans' quality of life.
Challenges in the Europe Respiratory Care Devices Market
High Cost of Devices
In the European market, the high price of respiratory care equipment is a major obstacle. Advanced devices including CPAP machines, ventilators, and portable oxygen concentrators can have high initial and ongoing costs. Especially for older people on fixed incomes and in lower-income areas, this restricts access. Furthermore, the financial strain on healthcare systems may cause delays in adoption and procurement, particularly in publically financed models. Affordability is therefore still a major obstacle to widespread use and fair healthcare delivery.
Regulatory Hurdles
The market for respiratory care equipment in Europe is severely hampered by regulatory barriers. There are now more stringent standards for clinical evaluation, labeling, and post-market surveillance as a result of the EU Medical Device Regulation (MDR). Although the goal of these laws is to guarantee safety and quality, they have resulted in longer approval times for businesses and higher compliance costs. Smaller businesses in particular struggle to manage these intricate procedures, which can impede innovation and market entry and, in turn, restrict patients' access to cutting-edge respiratory care solutions.
Key Players Analyzed: Overview, Key Persons, Recent Developments, Financial Insights
Medtronic Plc Koninklijke Philips General Electric Company Masimo Corporation ResMedInc Becton, Dickinson and Company Chart Industries Inc Getinge AB
Key Attributes:
CONTACT:
CONTACT:
Laura Wood,Senior Press Manager
...
For E.S.T Office Hours Call 1-917-300-0470
For U.S./ CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Comments
No comment